| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.84M | - | |
| Other | 133.1K | $3.46M | - | |
| CEO | 132.7K | $3.45M | - | |
| CFO | 105.7K | $2.75M | - | |
| VP | 95.7K | $2.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2020 | Huizenga Theodore Alan65 | SVP, Controller And Pao | Sell | 1,000 | $61.00 | $61,000.00 | -5.9% | |
| Sep 11, 2019 | Kakkis Emil D72 | President &CEO | Buy | 5,000 | $43.63 | $218,150.00 | +1.1% | |
| Jun 24, 2019 | Parschauer Karah Herdman77 | EVP And General Counsel | Sell | 2,715 | $62.33 | $169,220.89 | -6.9% | |
| Apr 29, 2019 | Parschauer Karah Herdman77 | EVP And General Counsel | Sell | 468 | $68.30 | $31,964.40 | -2.3% | |
| Mar 18, 2019 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 14,800 | $70.00 | $1,036,000.00 | -18.2% | |
| Dec 7, 2018 | Aliski William | Director | Sell | 6,000 | $49.69 | $298,140.00 | -6.2% | |
| Nov 8, 2018 | Aliski William | Director | Sell | 6,000 | $55.67 | $334,020.00 | -5.9% | |
| Sep 25, 2018 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 6,700 | $90.07 | $603,469.00 | -11.8% | |
| Aug 21, 2018 | Parschauer Karah Herdman77 | EVP And General Counsel | Sell | 5,000 | $78.53 | $392,650.00 | -35.3% | |
| Aug 8, 2018 | Aliski William | Director | Sell | 3,750 | $76.66 | $287,475.00 | -4.9% |